Ex Vivo Hepatocyte Reprograming Promotes Homology-Directed DNA Repair to Correct Metabolic Disease in Mice After Transplantation-Reference-Cited by-同舟云学术

Ex Vivo Hepatocyte Reprograming Promotes Homology-Directed DNA Repair to Correct Metabolic Disease in Mice After Transplantation

Published:2019-02-15 Issue:4 Volume:3 Page:558-573
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

VanLith Caitlin J.¹²,Guthman Rebekah M.¹²,Nicolas Clara T.¹,Allen Kari L.¹,Liu Yuanhang³,Chilton Jennifer A.⁴,Tritz Zachariah P.⁵⁶,Nyberg Scott L.¹⁷,Kaiser Robert A.¹⁸,Lillegard Joseph B.¹⁸⁹,Hickey Raymond D.¹²

Affiliation:

1. Department of Surgery; Mayo Clinic; Rochester MN

2. Department of Molecular Medicine; Mayo Clinic; Rochester MN

3. Division of Biomedical Statistics and Informatics; Mayo Clinic; Rochester MN

4. Charles River; Preclinical Services; Reno NV

5. Department of Immunology; Mayo Clinic; Rochester MN

6. Mayo Clinic Graduate School of Biomedical Sciences; Mayo Clinic; Rochester MN

7. William J. von Liebig Center for Transplantation and Clinical Regeneration; Mayo Clinic; Rochester MN

8. Midwest Fetal Care Center; Children’s Hospital and Clinics of Minnesota; Minneapolis MN

9. Pediatric Surgical Associates; Minneapolis MN

Funder

Regenerative Medicine Minnesota

Children's Hospital of Minnesota Foundation

Mayo Clinic Center for Regenerative Medicine Career Development Award

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep4.1315/fullpdf

Reference46 articles.

1. Human hepatocyte transplantation: current experience and future challenges;Dhawan;Nat Rev Gastroenterol Hepatol,2010

2. De Novo Donor-specific HLA antibody formation in two patients with Crigler-Najjar syndrome type I following human hepatocyte transplantation with partial hepatectomy preconditioning;Jorns;Am J Transpl,2016

3. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia;Grossman;Nat Med,1995

4. Hepatic lentiviral gene transfer is associated with clonal selection, but not with tumor formation in serially transplanted rodents;Rittelmeyer;Hepatology,2013

5. Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates;Menzel;Mol Ther,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases;Cell Stem Cell;2024-08

2. Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1;Hepatology Communications;2024-04-26

3. EX VIVO GENE EDITING AND CELL THERAPY FOR HEREDITARY TYROSINEMIA TYPE 1;2023-09-05

4. Development of in vitro gene editing therapy in disease treatment;Highlights in Science, Engineering and Technology;2023-03-21

5. Activation of homology-directed DNA repair plays key role in CRISPR-mediated genome correction;Gene Therapy;2022-10-19